Estimation of binding rate constants using a simultaneous mixed‐effects method: application to monoamine transporter reuptake inhibitor reboxetine
Neil Benson(Pfizer (United Kingdom)), Piet H. van der Graaf(Pfizer (United Kingdom)), Harriet Sale(Pfizer (United Kingdom)), Carolyn Napier(Pfizer (United Kingdom)), Bart A. Ploeger, Nelleke Snelder(Zero to Three), Richard P. Butt(Pfizer (United States)), N.J.M. Birdsall(The Francis Crick Institute)
Cited by 16
Related Papers
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
|Pharmacological Reviews|1998|1.5k
Muscarinic Receptor Subtypes
|The Annual Review of Pharmacology and Toxicology|1990|1.3k
The Binding of Agonists to Brain Muscarinic Receptors
|Molecular Pharmacology|1978|676
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488